Tryton Medical, Inc., located in Research Triangle Park, N.C. wants to solve the big problem of bifurcated coronary lesions. According to the company, cardiologists in Europe will soon be able to stent side branches thanks to the company’s proprietary Side Branch Stent System™. 
The stent system has received CE Mark approval in Europe, and will soon be launched in The Netherlands, to be followed by other European countries. This stent has not been cleared by the FDA for marketing in the United States.
From the product page:
The Tryton Side Branch Stent System is designed to treat a wide spectrum of bifurcated lesions. The system’s highly deliverable stent is deployed in the side branch artery using a standard single-wire balloon-expandable stent delivery system. A conventional drug eluting stent is then placed in the main vessel.
The Side Branch Stent features a low-profile cobalt chromium design compatible with 5F guide catheters. The stent’s unique three-zone design provides superior scaffolding within the side branch, radial strength in the transition zone, and minimal coverage in the main vessel zone.
This unique system has demonstrated excellent initial clinical results and is available for sale in Europe.
Product brochure: Tryton Medical – Side Branch Stent (.pdf) …
Press release: Tryton Medical Announces European Launch of Stent System for Bifurcation Lesions
